Johnson & Johnson Vision Announces New Appointment
Friday, May 1 2020 | 16 h 06 min | News
Johnson & Johnson Vision has appointed Rajesh K. Rajpal, M.D. as Chief Medical Officer and Global Head of Clinical and Medical Affairs.
In this role, Dr. Rajpal will lead the integration of rapidly evolving medical and clinical insights into new product development to address unmet needs of patients and eye care professionals around the world. He will also oversee clinical trials and the generation of surgical and vision care evidence, and serve as the critical liaison to government agencies and to the academic, scientific, and industry communities.
Dr. Rajpal joins Johnson & Johnson Vision from Avedro, where he served as Chief Medical Officer. Active in research and professional education, Dr. Rajpal has served as principal investigator in numerous clinical trials, authored multiple original peer-reviewed publications and textbook chapters, and has lectured internationally on topics related to corneal disease, cataract and refractive surgery.
He is the founder of the See Clearly Vision Group, an ophthalmology and optometry group practice with multiple offices in the metropolitan Washington, D.C. area.
Dr. Rajpal earned his medical degree and completed his residency in Ophthalmology at the Medical College of Virginia followed by a Fellowship in Cornea and External Diseases at Wills Eye Hospital in Philadelphia.
Click HERE for the full press release.
